Tech Company M&A Transactions

MedPointe Acquisition

MedPointe was acquired by Meda AB. The deal occurred on 7/23/2007. The acquisition price was $823 million.

Transaction Overview

Company Name
Acquired By
Announced On
7/23/2007
Transaction Type
M&A
Amount
$823,000,000
M&A Terms
The transaction was composed of $520 million cash and the remainder in Meda AB stock.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
265 Davidson Ave. 300
Somerset, NJ 08873
USA
Email Address
Not Recorded
Overview
MedPointe is a specialty pharmaceutical company that develops, markets and sells branded prescription therapeutics. Although the company was founded in 2001, it draws upon a long history. It entered the market with the acquisition of Carter-Wallace, Inc., a long-established enterprise. MedPointe is headquartered in Somerset, New Jersey, in the heart of the nation's pharmaceutical corridor.
Profile
MedPointe LinkedIn Company Profile
Social Media
MedPointe Company Twitter Account
Company News
MedPointe News
Facebook
MedPointe on Facebook
YouTube
MedPointe on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Edick
  Paul Edick LinkedIn Profile  Paul Edick Twitter Account  Paul Edick News  Paul Edick on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/23/2007: NeuroDerm venture capital transaction
Next: 7/23/2007: Solaria venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary